 Zacks Investment Research downgraded shares of Heska NASDAQ:HSKA from a buy rating to a hold rating in a research report sent to investors on Tuesday morning, Zacks.com reports. According to Zacks, Heska Corporation sells advanced veterinary diagnostic and specialty products. Heskas state-of-the-art offerings include blood testing instruments and supplies, digital imaging products, software and services, ... 